SCHEMBL5016241

SCHEMBL5016241

COc1cc(OC)c(CN2CCN(c3ccc([O])c4ncsc34)CC2)c(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
MAPK1 P28482 2/20 0.40
DRD2 P14416 5/20 0.39
DRD3 P35462 5/20 0.39
LMNA P02545 3/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
DRD4 P21917 2/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HTR1A P08908 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5016249 0.88 SMN1; SMN2 (0.45) KDM4EMAPK1DRD2DRD3LMNA
SCHEMBL2093990 0.84 ADORA2A (0.35) KDM4EDRD2DRD3ALDH1A1MAPT
SCHEMBL27644609 0.81 DRD2 (0.48) KDM4EMAPK1DRD2DRD3LMNA
SCHEMBL5013440 0.81 TP53 (0.36) KDM4ELMNAALDH1A1MAPTHTR1A
SCHEMBL2091406 0.79 ACACB (0.34) MAPTHTR1A
SCHEMBL2093999 0.72 ADORA2A (0.35) KDM4EDRD2DRD3LMNAALDH1A1
SCHEMBL5546069 0.70 KDM4E (0.49) KDM4EMAPK1DRD2DRD3LMNA
SCHEMBL2095879 0.67
SCHEMBL5016235 0.67 RAB9A (0.46) KDM4EDRD2DRD3LMNAALDH1A1
SCHEMBL2091415 0.67 ACACB (0.34) LMNAKMT2AMEN1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed